NORGES BANK - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$32,919,000
-10.6%
278,011
-10.9%
0.01%
-11.1%
Q4 2020$36,833,000
+6.3%
311,8530.0%0.01%0.0%
Q3 2020$34,659,000
-8.0%
311,853
-15.4%
0.01%
-18.2%
Q2 2020$37,684,000
-7.5%
368,801
-2.3%
0.01%
-26.7%
Q1 2020$40,733,000
-13.2%
377,401
-6.4%
0.02%
+15.4%
Q4 2019$46,932,000
+1.7%
403,2630.0%0.01%
-7.1%
Q3 2019$46,162,000
+20.1%
403,2630.0%0.01%
+16.7%
Q2 2019$38,431,000
+4.4%
403,2630.0%0.01%0.0%
Q1 2019$36,798,000
+59.4%
403,263
+32.6%
0.01%
+33.3%
Q4 2018$23,082,000
-5.1%
304,0750.0%0.01%
+12.5%
Q3 2018$24,326,000
-7.3%
304,075
+15.1%
0.01%
-11.1%
Q2 2018$26,236,000
+22.6%
264,1310.0%0.01%
+12.5%
Q1 2018$21,395,000
+2.8%
264,1310.0%0.01%
+14.3%
Q4 2017$20,806,000
-14.6%
264,1310.0%0.01%
-22.2%
Q3 2017$24,371,000264,1310.01%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2020
NameSharesValueWeighting ↓
Maso Capital Partners Ltd 164,500$15,011,00010.32%
HHLR ADVISORS, LTD. 2,751,200$251,047,0006.99%
Dalton Investments, Inc. 113,851$10,389,0004.54%
Point72 Hong Kong Ltd 115,939$10,579,0004.17%
York Capital Management Global Advisors, LLC 991,233$90,450,0004.05%
RUDMAN ERROL M 58,000$5,293,0003.57%
Greenwoods Asset Management Ltd 479,580$43,762,0002.69%
Parametrica Management Ltd 3,663$334,0000.71%
Temasek Holdings (Private) Ltd 990,000$90,338,0000.62%
Athos Capital Ltd 8,290$756,0000.49%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders